Drug Utilization Review Board
Meeting Agenda
Thursday, January 9, 2024
7:15 a.m to 8:30 a.m
Google Meet joining info
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306 #
Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon M Weinstein, MD
2) Welcome and Introductions - Sharon M Weinstein, MD
a) Housekeeping
i) Welcoming new DUR Board member & update on DURB Board manager
b) Review and Approval of Minutes
3) P&T Update - Ngan Huynh, PharmD
4) Review
a) Amondys 45 (casimersen), Exondys 51 (eteplirsen), Vyondys 53 (golodirsen), Viltepso (viltolarsen) Prior Authorization - Ngan Huynh, PharmD
i) Committee Discussion/Questions
b) Fabry Disease (Elfabrio, Fabrazyme, Galafold) Prior Authorization - Stephanie Byrne, PharmD
i) Committee Discussion/Questions
5) Next Meeting
a) February 13, 2025 - CAR-T Cell therapy Review
6) Adjourned
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Ngan Huynh at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/zue-rrqz-rpb
Or dial: (US) +1 904-900-0180 PIN: 172 873 306 #